CBWTF (Auxly Cannabis Group) YoY EBITDA Growth: -22.83% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CBWTF Auxly Cannabis Group Inc CBWTF
37 GF Score
Price $2.37
GF Value $0.63
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Auxly Cannabis Group YoY EBITDA Growth?

Auxly Cannabis Group CBWTF -0.03% 37 YoY EBITDA Growth is -22.83% as of Jun. 2026. GuruFocus rates CBWTF with a GF Score™ of 37/100 and a GF Value™ of $0.63 (Significantly Overvalued). The stock has 7 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Auxly Cannabis Group's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was -22.83%.

Auxly Cannabis Group's EBITDA per Share for the three months ended in Jun. 2026 was $0.07.

Auxly Cannabis Group YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Auxly Cannabis Group's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Auxly Cannabis Group YoY EBITDA Growth Chart

Auxly Cannabis Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 77.19 -330.59 89.53 273.04 61.81

Auxly Cannabis Group Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.33 114.49 -53.85 -22.58 -22.83
CBWTF
37GF Score
Auxly Cannabis Group Inc CBWTF
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Auxly Cannabis Group YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Auxly Cannabis Group's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(0.322-0.199)/ | 0.199 |
=61.81 %

Auxly Cannabis Group's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(0.071-0.092)/ | 0.092 |
=-22.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -22.83% mean?
Auxly Cannabis Group (CBWTF) has a YoY EBITDA Growth of -22.83% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Auxly Cannabis Group and its competitors.
Is Auxly Cannabis Group's YoY EBITDA Growth too high?
Auxly Cannabis Group's current YoY EBITDA Growth is -22.83%. Overall, Auxly Cannabis Group has a GF Score™ of 37/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Auxly Cannabis Group's YoY EBITDA Growth compare to ZTS?
Auxly Cannabis Group's YoY EBITDA Growth of -22.83% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Drug Manufacturers company?
A good YoY EBITDA Growth depends on the Drug Manufacturers industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Auxly Cannabis Group and its competitors. Auxly Cannabis Group's current YoY EBITDA Growth is -22.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Auxly Cannabis Group stock overvalued right now?
Based on GuruFocus' analysis, Auxly Cannabis Group (CBWTF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.63, compared to a current price of $2.37 — trading 276.1% above its estimated fair value. The current YoY EBITDA Growth is -22.83%. Auxly Cannabis Group's overall GF Score™ is 37/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Auxly Cannabis Group (CBWTF), the current YoY EBITDA Growth is -22.83% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Auxly Cannabis Group (CBWTF) Overvalued in 2026?

Based on GuruFocus' analysis, Auxly Cannabis Group stock appears to be overvalued. The current stock price of $2.37 is trading 276.1% above its estimated GF Value™ of $0.63. GuruFocus considers Auxly Cannabis Group to be Significantly Overvalued.

Key valuation signals for CBWTF:

  • YoY EBITDA Growth: -22.83%
  • GF Value™: $0.63 vs. price of $2.37 (276.1% above fair value)
  • GF Score™: 37/100 with 7 warning signs

No single metric tells the full story. See the CBWTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Auxly Cannabis Group Business Description

Other Exchanges 3KF:GermanyXLY:Canada
Address 777 Richmond Street West, Unit 002, Toronto, ON, CAN, M6J 0C2
Auxly Cannabis Group Inc is a consumer-packaged-goods company in the cannabis products market. The company has created a portfolio of brands designed for a broad market of cannabis consumers, with differentiation in price points across targeted consumer segments. Its product portfolio comprises dried cannabis, fresh cannabis, cannabis plants, cannabis seeds, cannabis oil, edible cannabis, cannabis extracts, and cannabis topicals, among others, which are marketed through brands like Parcel, Black Forty, Foray, Dosecann, and Kolab Project.
37GF Score

Get the complete analysis for CBWTF

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.37
Price
$0.63
GF Value